Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • Bitcoin USD

    63,872.99
    +113.68 (+0.18%)
     

  • CMC Crypto 200

    1,378.78
    +66.16 (+5.03%)
     

  • S&P 500

    4,970.49
    -40.63 (-0.81%)
     

  • Dow

    37,853.46
    +78.08 (+0.21%)
     

  • Nasdaq

    15,328.08
    -273.42 (-1.75%)
     

  • Gold

    2,406.00
    +8.00 (+0.33%)
     

  • Crude Oil

    83.00
    +0.27 (+0.33%)
     

  • 10-Yr Bond

    4.6080
    -0.0390 (-0.84%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Merck aims to hike revenues in China to one billion euro by 2018

Reuters

FRANKFURT (Reuters) - Merck will start offering non-prescription drugs in China as part of a push to double revenues in the region to 1 billion euros (1.02 billion pounds) by 2018, Chief Executive Karl-Ludwig Kley told German weekly Wirtschaftswoche.

Merck will focus on treatments related to diabetes, thyroid issues and heart problems, and supply medication made at a new factory in Nantong which is due to start production in 2017, Wirtschaftswoche said.

(Reporting by Edward Taylor; Editing by Ruth Pitchford)